Developing Sustainable Pathways In Prostate Cancer During COVID-19 & Beyond

The UKCPA/JOMO study day has become the main event in the respiratory pharmacy calendar. Despite the challenges this year this speakers and sessions were excellent.
NHS attendee at the UKCPA/JOMO respiratory study day
Event Name Developing Sustainable Pathways In Prostate Cancer During COVID-19 & Beyond
Location Webinar
Start Date 6:00pm 04/11/2020
Finish Date 7:30pm 04/11/2020
Booking Closes 5:00pm 03/11/2020
Places Available
Event Description

Pharmacy Management has been commissioned by Ferring Pharmaceuticals to co-ordinate and facilitate an educational webinar on Wednesday 4 November 2020.

The webinar is entitled 'Developing Sustainable Pathways In Prostate Cancer During COVID-19 & Beyond: Sharing best practice to initiate and maintain change for the better' and will cover:


  • Commissioning for success post COVID-19
  • Oncology care during and after COVID-19
  • Optimising the diagnostic pathway to reduce patient visits
  • Cardiovascular risk mitigation in prostate cancer

The webinar will conclude with a panel discussion group focusing on:


  • What has worked well and how do we ensure that positive change is driven, maintained and established
  • Personalising treatment for patients to optimise outcomes but also NHS resource
  • Minimising overall risk for patients whilst improving outcomes post COVID-19

The webinar will commence at 6pm and conclude at 7.30pm.


This webinar is organised and funded by Ferring Pharmaceuticals Ltd and is intended for healthcare professionals only.

Prescribing information will be available at this webinar.


September 2020

Agenda Download Agenda PDF
Contact Name Katie Fraser
More Details Email for more details.
Your booking is always provisional until we confirm it!
Login Register
Website by MAXX Design

© 2020 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions


This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.